Eligibility for some cancer screening programs has recently been expanded to reflect the increasing cancer rates among ...

UC San Diego study of global lung cancer shows mutations that lead to cancer are common in people who live in cities with bad air pollution. But cancer mutations are quite close to normal among ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are ...

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

The aim is to find and treat lung cancers early, before they grow and spread, to improve the chance of survival. Here’s ...

A sweeping new report from the American Cancer Society suggests cancer will likely be the leading cause of early deaths worldwide by 2050, with cases projected to rise by 74%. "Th ...